Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Secures $3M Bridge Financing from Silicon Valley Bank

NEW YORK, Jan. 3 (GenomeWeb News) - Lynx Therapeutics has obtained a $3 million bridge loan from Silicon Valley Bank, the company said last week.


The financing, which is secured by Lynx's assets, will keep the company going as it prepares to be acquired by Solexa. It will support Lynx's operations until the company completes an equity financing sometime this year, acting CEO Mary Schramke said in a statement.


The acquisition by Solexa, which still needs to be approved by Lynx and Solexa shareholders, is expected to close in the first quarter of 2005.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.